Involvement of human endogenous retroviral syncytin-1 in human osteoclast fusion. 2011

Kent Søe, and Thomas L Andersen, and Anne-Sofie Hobolt-Pedersen, and Bolette Bjerregaard, and Lars-Inge Larsson, and Jean-Marie Delaissé
Department of Clinical Cell Biology, Vejle Hospital, IRS/CSFU, University of Southern Denmark, Kabbeltoft 25, 7100 Vejle, Denmark. kent.soee@slb.regionsyddanmark.dk

Generation of osteoclasts through fusion of mono-nucleated precursors is a key event of bone physiology and bone resorption is inefficient without osteoclast fusion. Several factors playing a critical role in the fusion process have already been recognized, but the factors involved in the actual fusion of the lipid bilayers of their cell membranes are still unknown. Syncytin-1 is a protein encoded by a human endogenous retroviral gene which was stably integrated into the human ancestor genome more than 24 million years ago. Upon activation, syncytin-1 is able to destabilize the lipid bilayer of the target cell and to force the merging of plasma membranes. This protein is a key player in the fusion of cytotrophoblasts. In the present study, syncytin-1 as well as its putative receptor ASCT2 was found to be expressed in differentiating osteoclasts in vitro, both on mRNA and protein level. This was documented through Q-PCR, Western blot and immunofluorescence analyses. These in vitro findings were confirmed by immunohistochemical stainings in human iliac crest biopsies. A syncytin-1 inhibitory peptide reduced the number of nuclei per osteoclast by 30%, as well as TRACP activity. From a mechanistic point of view, it is interesting that the distribution of syncytin-1 immunoreactivity on the cell surface parallels that of actin, another important player in cell fusion, and that cell-cell proximity induces particular patterns of distribution of syncytin-1 and actin in the respective cells. These complementary observations support a critical role of syncytin-1 in osteoclast fusion, which is of special interest in view of its well-known ability to force the merging of plasma membranes.

UI MeSH Term Description Entries
D010010 Osteoclasts A large multinuclear cell associated with the BONE RESORPTION. An odontoclast, also called cementoclast, is cytomorphologically the same as an osteoclast and is involved in CEMENTUM resorption. Odontoclasts,Cementoclast,Cementoclasts,Odontoclast,Osteoclast
D011257 Pregnancy Proteins Proteins produced by organs of the mother or the PLACENTA during PREGNANCY. These proteins may be pregnancy-specific (present only during pregnancy) or pregnancy-associated (present during pregnancy or under other conditions such as hormone therapy or certain malignancies.) Placental Proteins,Proteins, Placental,Proteins, Pregnancy
D002459 Cell Fusion Fusion of somatic cells in vitro or in vivo, which results in somatic cell hybridization. Cell Fusions,Fusion, Cell,Fusions, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D005260 Female Females
D005455 Fluorescent Antibody Technique Test for tissue antigen using either a direct method, by conjugation of antibody with fluorescent dye (FLUORESCENT ANTIBODY TECHNIQUE, DIRECT) or an indirect method, by formation of antigen-antibody complex which is then labeled with fluorescein-conjugated anti-immunoglobulin antibody (FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT). The tissue is then examined by fluorescence microscopy. Antinuclear Antibody Test, Fluorescent,Coon's Technique,Fluorescent Antinuclear Antibody Test,Fluorescent Protein Tracing,Immunofluorescence Technique,Coon's Technic,Fluorescent Antibody Technic,Immunofluorescence,Immunofluorescence Technic,Antibody Technic, Fluorescent,Antibody Technics, Fluorescent,Antibody Technique, Fluorescent,Antibody Techniques, Fluorescent,Coon Technic,Coon Technique,Coons Technic,Coons Technique,Fluorescent Antibody Technics,Fluorescent Antibody Techniques,Fluorescent Protein Tracings,Immunofluorescence Technics,Immunofluorescence Techniques,Protein Tracing, Fluorescent,Protein Tracings, Fluorescent,Technic, Coon's,Technic, Fluorescent Antibody,Technic, Immunofluorescence,Technics, Fluorescent Antibody,Technics, Immunofluorescence,Technique, Coon's,Technique, Fluorescent Antibody,Technique, Immunofluorescence,Techniques, Fluorescent Antibody,Techniques, Immunofluorescence,Tracing, Fluorescent Protein,Tracings, Fluorescent Protein
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D015153 Blotting, Western Identification of proteins or peptides that have been electrophoretically separated by blot transferring from the electrophoresis gel to strips of nitrocellulose paper, followed by labeling with antibody probes. Immunoblotting, Western,Western Blotting,Western Immunoblotting,Blot, Western,Immunoblot, Western,Western Blot,Western Immunoblot,Blots, Western,Blottings, Western,Immunoblots, Western,Immunoblottings, Western,Western Blots,Western Blottings,Western Immunoblots,Western Immunoblottings
D015686 Gene Products, env Retroviral proteins, often glycosylated, coded by the envelope (env) gene. They are usually synthesized as protein precursors (POLYPROTEINS) and later cleaved into the final viral envelope glycoproteins by a viral protease. env Gene Products,env Polyproteins,env Protein,env Antigens,env Glycoproteins,env Polyprotein,Antigens, env,Polyprotein, env,Polyproteins, env

Related Publications

Kent Søe, and Thomas L Andersen, and Anne-Sofie Hobolt-Pedersen, and Bolette Bjerregaard, and Lars-Inge Larsson, and Jean-Marie Delaissé
November 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology,
Kent Søe, and Thomas L Andersen, and Anne-Sofie Hobolt-Pedersen, and Bolette Bjerregaard, and Lars-Inge Larsson, and Jean-Marie Delaissé
January 2018, Frontiers in psychiatry,
Kent Søe, and Thomas L Andersen, and Anne-Sofie Hobolt-Pedersen, and Bolette Bjerregaard, and Lars-Inge Larsson, and Jean-Marie Delaissé
April 2019, The Journal of general virology,
Kent Søe, and Thomas L Andersen, and Anne-Sofie Hobolt-Pedersen, and Bolette Bjerregaard, and Lars-Inge Larsson, and Jean-Marie Delaissé
June 2017, Journal of cellular physiology,
Kent Søe, and Thomas L Andersen, and Anne-Sofie Hobolt-Pedersen, and Bolette Bjerregaard, and Lars-Inge Larsson, and Jean-Marie Delaissé
July 2012, Journal of cellular biochemistry,
Kent Søe, and Thomas L Andersen, and Anne-Sofie Hobolt-Pedersen, and Bolette Bjerregaard, and Lars-Inge Larsson, and Jean-Marie Delaissé
January 2007, Journal of molecular medicine (Berlin, Germany),
Kent Søe, and Thomas L Andersen, and Anne-Sofie Hobolt-Pedersen, and Bolette Bjerregaard, and Lars-Inge Larsson, and Jean-Marie Delaissé
August 2004, Molecular human reproduction,
Kent Søe, and Thomas L Andersen, and Anne-Sofie Hobolt-Pedersen, and Bolette Bjerregaard, and Lars-Inge Larsson, and Jean-Marie Delaissé
May 2005, Journal of virology,
Kent Søe, and Thomas L Andersen, and Anne-Sofie Hobolt-Pedersen, and Bolette Bjerregaard, and Lars-Inge Larsson, and Jean-Marie Delaissé
March 2020, Cell reports,
Kent Søe, and Thomas L Andersen, and Anne-Sofie Hobolt-Pedersen, and Bolette Bjerregaard, and Lars-Inge Larsson, and Jean-Marie Delaissé
January 2007, Apoptosis : an international journal on programmed cell death,
Copied contents to your clipboard!